Table 6B.
Additional prescription sequence symmetry analysis. Patients who initiated a new treatment with benzodiazepines and anti-dementia drugs within 24-month period were excluded from the analysis.
Interval(months) | No. of patients prescribed anti-dementia drugs | Adjusted SR | 95% CI | ||||
---|---|---|---|---|---|---|---|
Lower | Upper | ||||||
Last | first | ||||||
Benzodiazepines | 36 | 281 | 78 | 2.99 | 2.32 | 3.90 | |
48 | 485 | 119 | 3.19 | 2.61 | 3.94 |
Incident users: number of patients who received their first prescription for benzodiazepines
No. of patients prescribed anti-dementia drugs last: the number of patients prescribed anti-dementia drugs after benzodiazepine use
No. of patients prescribed anti-dementia drugs last: the number of patients prescribed anti-dementia drugs before benzodiazepine use
Adjusted SR: adjusted sequence ratio
CI: confidence interval